Drug Trial Radar · NCT05995405
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH
Last checked: Nov 19, 2026Latest source record: Oct 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Oct 20, 2023
Primary completion
Dec 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- Grace Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 16, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine capsules.
Conditions
- Aneurysmal Subarachnoid Hemorrhage (aSAH)
Interventions
GTX-104Drug
Nimodipine IV infusion
Nimotop 30 MG Oral CapsuleDrug
Oral nimodipine capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence (% or proportion) of subjects with at least one episode of clinically significant hypotension with a reasonable possibility that GTX-104/oral nimodipine caused the event, according to the Endpoint Adjudication Committee.Time frame: 90 days
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama
Brain and Spine Neurological Institute
Phoenix, Arizona
Community Regional Medical Center
Fresno, California
Mayo Clinic Florida
Jacksonville, Florida
Emory University School of Medicine Emergency Neurosciences
Atlanta, Georgia
Northwestern Feinberg Pavillion Neuro and Spine ICU
Chicago, Illinois
Indiana University Health Methodist Hospital
Indianapolis, Indiana
University of Kentucky Hospital
Lexington, Kentucky
University of Maryland Medical Center
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Washington University
St Louis, Missouri
The Mount Sinai Hospital
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Duke University
Durham, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center
Columbus, Ohio
Oregon Health and Science University
Portland, Oregon
Methodist University Hospital
Memphis, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee
University of Texas Health Science Center at Houston
Houston, Texas
Virginia Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.